Indo Borax & Chemicals Limited has appointed Suresh Kalra as Managing Director and Chief Executive Officer and Shashikant Bharuka as Chief Financial Officer and Key Managerial Personnel of its recently acquired subsidiary, Kronox Lab Sciences Limited. The appointments follow Indo Borax’s acquisition of a 64.26% stake in Kronox Lab Sciences, completed on September 29, 2026. The change in leadership marks the beginning of a new phase for Kronox following the change in shareholding.
Mr Kalra has been appointed as Managing Director and CEO for a five-year term. He brings more than 25 years of experience in the chemicals industry, with expertise spanning global operations, profit and loss management, manufacturing, strategic planning and international business development. His experience includes working across India, the United States, the Middle East and the Asia-Pacific region. At Kronox, he will be responsible for leading the company’s operations and working with the Board and management team on its growth plans.
“Kronox has built a strong foundation in high-purity speciality chemicals, supported by its manufacturing capabilities, technical expertise and growing presence across domestic and international markets,” said Suresh Kalra, Managing Director and CEO, Kronox Lab Sciences Ltd. “I am excited to join the Company at this important juncture and look forward to working closely with the Board and the team to build on this foundation. Our focus will be on strengthening operations, expanding our capabilities, deepening customer relationships and pursuing sustainable growth opportunities across India and global markets,” he added.
Shashikant Bharuka has been appointed Chief Financial Officer and Key Managerial Personnel of Kronox. The new leadership team will work with the reconstituted Board to oversee the company’s business, financial management and expansion plans. The new Board brings together experience in chemicals and manufacturing, financial management, banking, legal affairs and corporate governance. Following the change in shareholding, Kronox has also reconstituted its Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee and Corporate Social Responsibility Committee.
Incorporated in 2008 and headquartered in Vadodara, Gujarat, Kronox Lab Sciences manufactures high-purity speciality fine chemicals, including excipients, reagents, buffers and intermediates. Its products serve pharmaceutical, nutraceutical, biotechnology, agrochemical, scientific research, laboratory testing, metallurgy and personal care industries.
Kronox operates multiple manufacturing units in Gujarat and has a portfolio of more than 185 products sold across domestic and export markets. The company reported revenue of approximately ₹101 crore and profit after tax of approximately ₹28 crore in FY2026.
Indo Borax & Chemicals, established in 1980, manufactures boron-based chemicals and boric acid. Its manufacturing facilities at Pithampur, Madhya Pradesh, produce boric acid, disodium octaborate tetrahydrate and borax. The company also manufactures Pharma Grade Boric Acid and was among the first companies in India to receive a BIS licence for Technical Grade Boric Acid.
